4.8 Article

Platelet P-selectin initiates cross-presentation and dendritic cell differentiation in blood monocytes

Journal

SCIENCE ADVANCES
Volume 6, Issue 11, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aaz1580

Keywords

-

Funding

  1. NIH [1R01CA026412, R01-AI097206, R01GM118486]
  2. NSF Graduate Research Fellowship Program
  3. Fahmy Lab
  4. Yale Cancer Center
  5. NY Cardiac Center [GS056321]
  6. NIAMSD Training Grant [5T32AR007016]
  7. Cancer Research Institute Irvington Postdoctoral Fellowship

Ask authors/readers for more resources

Dendritic cells (DCs) are adept at cross-presentation and initiation of antigen-specific immunity. Clinically, however, DCs produced by in vitro differentiation of monocytes in the presence of exogenous cytokines have been met with limited success. We hypothesized that DCs produced in a physiological manner may be more effective and found that platelets activate a cross-presentation program in peripheral blood monocytes with rapid (18 hours) maturation into physiological DCs (phDCs). Differentiation of monocytes into phDCs was concomitant with the formation of an adhesion synapse, a biophysical junction enriched with platelet P-selectin and monocyte P-selectin glycoprotein ligand 1, followed by intracellular calcium fluxing and nuclear localization of nuclear factor icB. phDCs were more efficient than cytokine-derived DCs in generating tumor-specific T cell immunity. Our findings demonstrate that platelets mediate a cytokine-independent, physiologic maturation of DC and suggest a novel strategy for DC-based immunotherapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available